- Home
- Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs
Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs
- Guidelines
- Heart Failure
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
This content is not intended for UK or US Health Care Professionals
Overview
During this unique broadcast, "Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. Radcliffe’s roundtable discussions are to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at forthcoming events via lively discussion and data presentations.
Dr Javed Butler (University of Mississippi Medical Center, Jackson, Mississippi, US) leads proceedings, and is joined by Dr Clyde Yancy (Northwestern University Feinberg School of Medicine, Illinois, US), Prof Faiez Zannad (University of Lorraine, Nancy, FR), and Prof Christiane Angermann (University Hospital of Würzburg, Würzburg, DE) for an insightful presentation and a discussion.
Disclosure
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. This programme is supported by an unrestricted educational grant from Boehringer Ingelheim.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session, ‘Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Support Statement
This programme is supported by an educational grant from the Boehringer Ingelheim and Lilly Alliance.
Instructions to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
This programme is intended to educate:
- Global Heart Failure Physicians
- General Cardiologists
Learning Objectives
Upon participation in the roundtable discussion physicians will be able to:
- Recall the utility of EF in heart failure treatment, patient selection and treatment response
- Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
- Incorporate quality of life measures for assessing therapeutic efficacy in HF
- Recall outcomes from heart failure trials from recent congress and publications and their impact on practice
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Session 1 | How is the landscape of HF Changing? | Javed Butler | |
| Session 2 | A Changing Paradigm in the Progression of HF Therapy Initiation | Christiane Angermann | |
| Session 2.2 | Roundtable Discussion | Javed Butler Christiane Angermann Clyde W Yancy Faiez Zannad | |
| Session 3 | An ESC 2022 Update: Relevant New Medical Data | Faiez Zannad | |
| Session 4 | Applying the Guidelines in Clinical Practice | Clyde W Yancy | |
| Session 5 | Roundtable Discussion: QOL, Implementation in Practice and Future Trials | Javed Butler Clyde W Yancy Faiez Zannad Christiane Angermann |
A Changing Paradigm in the Progression of HF Therapy Initiation
Duration:
Speakers: Christiane Angermann
Roundtable Discussion
Duration:
Speakers: Javed Butler Christiane Angermann Clyde W Yancy Faiez Zannad
Roundtable Discussion: QOL, Implementation in Practice and Future Trials
Duration:
Speakers: Javed Butler Clyde W Yancy Faiez Zannad Christiane Angermann
Related Courses
- 0.50
Published:
Learning objectives
- Recall recent trial data for novel disease modifying therapy in HCM
- Describe the evolving guideline directed approach to managing HCM
- Develop an expert-led approach to implementing novel therapy in clinical practice
- 1.00
Published:
Learning objectives
- Recall guideline updates relevant to the use of disease modifying agents in hypertrophic cardiomyopathy
- Identify patients who, according to guidelines, may benefit from emerging disease modifying therapies prior to septal ablation therapy or being managed by symptom control alone
- Discuss long-term management strategies for patients receiving myosin inhibitor therapy
- 1.00
Published:
Learning objectives
- Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
- Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
- Select appropriate imaging modalities to facilitate accurate risk stratification
- Stratify patients based on specific risk features and disease severity
- Choose suitable treatment modalities for patients based on specific disease features and severity